Showing results (631-640 of 1,526) with videos related to

Sort By:
Pageof 153
Clinical Pharmacology and Therapeutics|February 2, 2021
Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19Jessica M Franklin, Kueiyu Joshua Lin, Nicolle M Gatto, et al.
Parkinsonism & Related Disorders|April 22, 2008
Dietary fats, cholesterol and iron as risk factors for Parkinson's diseaseKaren M Powers, Terri Smith-Weller, Gary M Franklin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 6, 2014
Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosisD H Solomon, E M Brown, D Chandler, et al.
Journal of General Internal Medicine|October 13, 2000
Communication breakdown in the outpatient referral processT K Gandhi, D F Sittig, M Franklin, et al.
European Journal of Radiology|July 13, 2015
Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?Nassim Parvizi, James M Franklin, Daniel R McGowan, et al.
Neurology|June 11, 2003
Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakesK M Powers, T Smith-Weller, G M Franklin, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2017
Do patients trust the FDA?: a survey assessing how patients view the generic drug approval processAaron S Kesselheim, Joshua J Gagne, Jessica M Franklin, et al.
Stem Cells Translational Medicine|May 17, 2013
Neural precursor cells cultured at physiologically relevant oxygen tensions have a survival advantage following transplantationSybil R L Stacpoole, Daniel J Webber, Bilada Bilican, et al.
Journal of General Internal Medicine|February 28, 2013
Changing interactions between physician trainees and the pharmaceutical industry: a national surveyKirsten E Austad, Jerry Avorn, Jessica M Franklin, et al.
Pageof 153